These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 24687923

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Zoledronic acid alters hematopoiesis and generates breast tumor-suppressive bone marrow cells.
    Ubellacker JM, Haider MT, DeCristo MJ, Allocca G, Brown NJ, Silver DP, Holen I, McAllister SS.
    Breast Cancer Res; 2017 Mar 06; 19(1):23. PubMed ID: 28264701
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Castration-induced bone loss triggers growth of disseminated prostate cancer cells in bone.
    Ottewell PD, Wang N, Meek J, Fowles CA, Croucher PI, Eaton CL, Holen I.
    Endocr Relat Cancer; 2014 Oct 06; 21(5):769-81. PubMed ID: 25052474
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antitumor effects of doxorubicin followed by zoledronic acid in a mouse model of breast cancer.
    Ottewell PD, Mönkkönen H, Jones M, Lefley DV, Coleman RE, Holen I.
    J Natl Cancer Inst; 2008 Aug 20; 100(16):1167-78. PubMed ID: 18695136
    [Abstract] [Full Text] [Related]

  • 9. Resveratrol for preventing medication-related osteonecrosis of the jaws in rats.
    Vitale M, Corrêa MG, Ervolino E, Cirano FR, Ribeiro FV, Monteiro MF, Casati MZ, Pimentel SP.
    Oral Dis; 2024 Apr 20; 30(3):1462-1474. PubMed ID: 36807967
    [Abstract] [Full Text] [Related]

  • 10. The effect of bone morphometric changes on orthodontic tooth movement in an osteoporotic animal model.
    Hashimoto M, Hotokezaka H, Sirisoontorn I, Nakano T, Arita K, Tanaka M, Yoshida N.
    Angle Orthod; 2013 Sep 20; 83(5):766-73. PubMed ID: 23445276
    [Abstract] [Full Text] [Related]

  • 11. Antagonism of inhibitor of apoptosis proteins increases bone metastasis via unexpected osteoclast activation.
    Yang C, Davis JL, Zeng R, Vora P, Su X, Collins LI, Vangveravong S, Mach RH, Piwnica-Worms D, Weilbaecher KN, Faccio R, Novack DV.
    Cancer Discov; 2013 Feb 20; 3(2):212-23. PubMed ID: 23269702
    [Abstract] [Full Text] [Related]

  • 12. Zoledronic acid enhances bone-implant osseointegration more than alendronate and strontium ranelate in ovariectomized rats.
    Chen B, Li Y, Yang X, Xu H, Xie D.
    Osteoporos Int; 2013 Jul 20; 24(7):2115-21. PubMed ID: 23389695
    [Abstract] [Full Text] [Related]

  • 13. Additive effects of zoledronic acid and propranolol on bone density and biochemical markers of bone turnover in osteopenic ovariectomized rats.
    Khajuria DK, Razdan R, Mahapatra DR.
    Rev Bras Reumatol; 2015 Jul 20; 55(2):103-12. PubMed ID: 25582996
    [Abstract] [Full Text] [Related]

  • 14. Death receptor 5 agonist TRA8 in combination with the bisphosphonate zoledronic acid attenuated the growth of breast cancer metastasis.
    Szafran AA, Folks K, Warram J, Chanda D, Wang D, Zinn KR.
    Cancer Biol Ther; 2009 Jun 20; 8(12):1109-16. PubMed ID: 19652526
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the in vitro and in vivo antiangiogenic effects of denosumab and zoledronic acid.
    Misso G, Porru M, Stoppacciaro A, Castellano M, De Cicco F, Leonetti C, Santini D, Caraglia M.
    Cancer Biol Ther; 2012 Dec 20; 13(14):1491-500. PubMed ID: 22990205
    [Abstract] [Full Text] [Related]

  • 16. Bone degeneration and recovery after early and late bisphosphonate treatment of ovariectomized wistar rats assessed by in vivo micro-computed tomography.
    Brouwers JE, Lambers FM, Gasser JA, van Rietbergen B, Huiskes R.
    Calcif Tissue Int; 2008 Mar 20; 82(3):202-11. PubMed ID: 18286219
    [Abstract] [Full Text] [Related]

  • 17. Preclinical evaluation of zoledronate using an in vitro mimetic cellular model for breast cancer metastatic bone disease.
    Dedes PG, Kanakis I, Gialeli Ch, Theocharis AD, Tsegenidis T, Kletsas D, Tzanakakis GN, Karamanos NK.
    Biochim Biophys Acta; 2013 Jun 20; 1830(6):3625-34. PubMed ID: 23395844
    [Abstract] [Full Text] [Related]

  • 18. Long-term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat.
    Gasser JA, Ingold P, Venturiere A, Shen V, Green JR.
    J Bone Miner Res; 2008 Apr 20; 23(4):544-51. PubMed ID: 18072878
    [Abstract] [Full Text] [Related]

  • 19. The combined use of Camellia sinensis and metronomic zoledronic acid in a breast cancer-induced osteolysis mouse model.
    Luo KW, Ko CH, Yue GG, Gao S, Lee JK, Li G, Fung KP, Leung PC, Evdokiou A, Lau CB.
    J Cancer Res Clin Oncol; 2015 Jun 20; 141(6):1025-36. PubMed ID: 25431338
    [Abstract] [Full Text] [Related]

  • 20. Anticancer mechanisms of doxorubicin and zoledronic acid in breast cancer tumor growth in bone.
    Ottewell PD, Woodward JK, Lefley DV, Evans CA, Coleman RE, Holen I.
    Mol Cancer Ther; 2009 Oct 20; 8(10):2821-32. PubMed ID: 19789217
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.